Therapeutic Pipeline Overview
A summary of our active AI-driven drug discovery programs across multiple infectious disease targets.
.png)
End-to-end AI-powered biotechnology solutions for drug discovery, sustainable biosurfactant production, and research collaboration.
AI-powered prediction platform for discovering therapeutics targeting Mycobacterium tuberculosis, the causative agent of tuberculosis.
AI platform focused on predicting compounds active against drug-resistant Klebsiella pneumoniae, a WHO high-priority pathogen.
AI platform targeting Pseudomonas aeruginosa, one of the WHO's highest-priority multidrug-resistant pathogens.
Proprietary biosurfactant production platform leveraging metabolically engineered fungal strains for sustainable biotechnology.
Molecules Screened
Specialized AI Models
Model Validation Accuracy
Research Partnerships
Partner with Living In Silico to accelerate AI-driven drug discovery, sustainable biotechnology, and computational biology research.
A summary of our active AI-driven drug discovery programs across multiple infectious disease targets.